1. Effect of ONO‐5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2‐Year Results From the OCEAN Study. (February 2014) Authors: Eastell, Richard; Nagase, Shinichi; Small, Maria; Boonen, Steven; Spector, Tim; Ohyama, Michiyo; Kuwayama, Tomohiro; Deacon, Steve Journal: Journal of bone and mineral research Issue: Volume 29:Number 2(2014:Feb.) Page Start: 458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Modeling and simulation of bone mineral density response from a phase 2 study of ONO‐5334, a new cathepsin K inhibitor, to support dose selection in osteoporosis. (28th February 2014) Authors: Hasegawa, Chihiro; Kastrissios, Helen; Monteleone, Jonathan; Ohno, Tomoya; Umemura, Takeo; Ohyama, Michiyo; Nagase, Shinichi; Small, Maria; Deacon, Steve; Ogawa, Mikio; Ieiri, Ichiro Journal: Journal of clinical pharmacology Issue: Volume 54:Number 8(2014:Aug.) Page Start: 937 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Effect of the Cathepsin K Inhibitor ONO‐5334 on Trabecular and Cortical Bone in Postmenopausal Osteoporosis: The OCEAN Study. (March 2014) Authors: Engelke, Klaus; Nagase, Shinichi; Fuerst, Thomas; Small, Maria; Kuwayama, Tomohiro; Deacon, Stephen; Eastell, Richard; Genant, Harry K Journal: Journal of bone and mineral research Issue: Volume 29:Number 3(2014:Mar.) Page Start: 629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗